[1]
« The Impact of Chimeric Antigen Receptor (CAR) T Cell Therapy: Its Potential to Reshape Rheumatology Practice », Can Rheumatol Today, vol. 2, nᵒ 1, p. 30–36, juin 2025, doi: 10.58931/crt.2025.2160.